IPC Partners
BIOMAP Collaboration Update: A Systemic Review on Biomarkers
Annually, the IPC Board selects a specific subject of importance and commissions a group of experts to conduct a best
Tuesday, September 27, 2022
Tag: Support Our Work
Commentaries
Commentary: Drug Survival Associated with Effectiveness and Safety of Treatment with Guselkumab, Ixekizumab, Secukinumab, Ustekinumab, and Adalimumab in Patients with Psoriasis
Real-world evidence studies become crucial to achieving the evidence needed in clinical practice. But how are data evaluated in the
Wednesday, August 31, 2022
Commentaries
Commentary: Prevalence and Factors Associated with Sleep Disturbance in Adult Patients with Psoriasis
Sleep disorders are frequently found in patients with psoriasis, but the specific factors have remained elusive and have never been
Thursday, July 21, 2022
COVID-19
PsoProtect Registry Data Update
PsoProtect, a global registry for clinicians to report outcomes of COVID-19 in individuals with psoriasis, has updated their preliminary data
Wednesday, June 15, 2022
Commentaries
Commentary: Biomarkers of Disease Progression in Psoriasis: Current State-of-the-Art
In personalized care for patients, psoriasis biomarkers will be highly relevant. At present, various centers have investigated biomarkers and their
Monday, June 13, 2022
Commentaries
Commentary: Vaccine Hesitancy and Access to Psoriasis Care in the COVID-19 Pandemic
The COVID-19 pandemic has been a significant concern, and vaccination has been crucial worldwide in its combat.
Wednesday, May 11, 2022
Commentaries
Commentary: IFN-k is a rheostat for development of psoriasiform inflammation
IPC Councilor, Carlo Pincelli, MD, shares his expert opinion on innovative research that connects insights into immunopathogenesis with genetics and
Tuesday, April 12, 2022
Commentaries
Commentary: Humoral and cellular immunogenicity to a second dose of COVID-19 vaccine BNT162b2 in people receiving methotrexate or targeted immunosuppression: a longitudinal cohort study
A research group led by Catherine Smith from St John’s Institute of Dermatology described humoral and cellular immunity.
Tuesday, January 25, 2022
COVID-19
Latin American Case Series
It is not fully understood the impact that COVID-19 has on psoriasis patients.
Wednesday, January 19, 2022
IPC Partners
World Psoriasis Day
Biologics and biosimilars have created many new options in psoriasis treatment for patients worldwide, but patients worldwide face barriers to
Thursday, October 28, 2021
